Breast cancer progression

Sgroi DC et al. In vivo gene expression profile analysis of human breast cancer progression. Cancer Res 1999 59 5656-5661. 

Howell A, Robertson JF, Quaresma AJ, Aschermannova A, Mauriac L, Kleeberg UR, Vergote I, Erikstein B, Webster A, Morris C (2002) Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment. J Clin Oncol 20 3396-3403... 

Osborne CK, Pippen J, Jones SE, Parker LM, Ellis M, Come S, Gertler SZ, May JT, Burton G, Dimery I, et al. (2002) Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy results of a North American trial. J Clin Oncol 20 3386-3395... 

Thomas ES, Gomez HL, Li RK, Chung H-C, Fein LE, Chan VF, Jassem J, Pivot XB, KJimovsky JV, de Mendoza FH, Xu B, Campone M, Lerzo GL, Peck RA, Mukhopadhyay P, Vahdat FT, Roche HH. (2007). Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. J Clin Oncol 25 5210-5217. 

Holliday DL, Broiulette KT, Markert A et al (2009) Novel multicellular organotypic models of normal and malignant breast tools for dissecting the role of the microenvironment in breast cancer progression. Breast Cancer Res 11 R3... 

Abba MC, Drake JA, Hawkins KA, Hu Y, Sun H, Notcovich C, Gaddis S, Sahin A, Baggerly K, Aldaz CM (2004) Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression. Breast Cancer Res 6 R499-R513... 

Rosen JM. Hormone receptor patterning plays a critical role in normal lobuloalveolar development and breast cancer progression. Breast Dis 2003 18 3-9. 

Cabanes, A., Wang, M., Olivo, S., Gustafsson, J., and Hilakivi-Clarke, L. (2003). Effect of n-3 polyunsaturated fatty acids (PUFAs) on breast cancer progression. Cancer Epidemiol. Biomarkers Prev. 12 (1305S). 

Liu XL, Wazer DE, Watanabe K, Band V. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer... 

Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 2003 100(10) 5974-5979. 

Swenson, S., Costa, F., Minea, R., Sherwin, R. P, Ernst, W., Fujii, G., Yang, D., and Markland, F. S., Jr. (2004), Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression, Mol. Cancer Then, 3,499-511. 

Ben-Baruch, A. (2003). Host microenvironment in breast cancer development Inflammatory cells, cytokines and chemokines in breast cancer progression Reciprocal tumor-microenvironment interactions. Breast Cancer Res. 5, 31-36. 

ERa serves as an example of a TF that is dependent on an HDAC for its activity (84). The reduction in expression of this nuclear receptor is a key step in the carcinogenesis of breast cancer and correlates with poor prognosis. ERa has been shown to bind HDACl directly in vitro and in vivo, and the overexpression of HDACl in MCF-7 cells leads to a reduction in both ERa protein levels and ERa transcriptional activity. Overexpression of HDACl also causes increased cell proliferation of MCE-7 cells (96). Thus, it has been suggested that HDACl plays a critical role in breast cancer progression. Consistent with this... 

Kawai H, et al. Overexpression of histone deacetylase HDAC 1 modulates breast cancer progression by negative regulation of estrogen receptor a. Internat. J. Cancer 2003 107 353-358. 

J.D. Wulfkuhle, K. McLean, D. Sgroi, A. Sahin, E. Petricoin and P. Steeg, Proteomic analysis of breast cancer progression. Clinical Cancer Research, 7, 3684s-3684s (2001). 

Ben-Baruch, A. 2006. Pro-malignancy and putative anti-malignancy chemokines in the regulation of breast cancer progression. Nova Science Publishers. 

Ghilardi, G., M. L. Biondi, A. La Torre, L. Battaglioli, and R. Scorza. 2005. Breast cancer progression and host polymorphisms in the chemokine system role of the macrophage chemoattractant protein-1 (MCP-1) -2518 G allele. Clin Chem 51 452. 

Jayasinghe, M. M., J.M. Golden, P. Nair, C. M. O Donnell, M. T. Werner, and R. A. Kurt. 2008. Tumor-derived CCL5 does not contribute to breast cancer progression. 

Lin, E. Y., and J. W. Pollard. 2004. Macrophages modulators of breast cancer progression. Novartis Found Symp 256 158. 

Ethier S.P., 1995, Growth factor synthesis and human breast cancer progression. J. Natl. Cancer Inst. 87 964-973. 

Ursini-Siegel J, Muller WJ. The ShcA adaptor protein is a critical regulator of breast cancer progression. Cell Cycle 2008 7 1936-1943. 

A. Santidrian, A. Matsuno-Yagi, M. Ritland, B. Seo, S. LeBoeuf, L. Gay, T. Yagi, and B. Felding-Habermann, Mitochondrial complex I activity and NAD +/NADH balance regulate breast cancer progression, y. Clin. Invest, 123 (2013) 1068-81. 

Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein TJ, Kaufmann M, Diebold J, Arnholdt H, Muller P, et al (2003) From latent disseminated cells to overt metastasis genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci U S A 100 7737-7742 Schulz W (2005) Molecular biology of human cancers. Springer, Netherlands... 

---